Purchase Order 75D30119P06477
Award Date 8/22/19
Potential Completion Date 4/29/24
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract was awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Illumina, Inc. to provide laboratory supplies. The contract has a potential value of $190,565.60 and was awarded on a firm fixed price basis with no set-aside designation. Illumina is a for-profit manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The company has previously received prime federal contract awards from...
- The Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) awarded a $247,008.03 firm fixed price purchase order contract to Illumina, Inc., a for-profit manufacturer of genetic sequencing and analysis products. The contract is for the provision of laboratory supplies, with a completion date of May 31, 2024. Illumina has previously received federal awards from agencies such as the National Institutes of Health (NIH), U.S. Department of Agriculture (USDA), and...
- The Centers for Disease Control and Prevention (CDC) awarded a $19,502 purchase order to Illumina, Inc. for lab supplies under a firm fixed price contract. The CDC, a component of the Department of Health and Human Services, supports programs focused on public health and disease prevention. This award will provide Illumina the opportunity to deliver laboratory materials to assist the CDC in carrying out its important mission over the approximately two-month period of performance ending in late...
- This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc. for the supply of lab supplies. The contract has a ceiling value of $97,152 and runs through February 28, 2017. The contract is not set aside for any special business designation. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis. Through past federal contract awards, Illumina has provided a range of...
- The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents, for reagents to be used with Illumina's sequencing systems. The $219,192.00 contract does not have a set-aside designation and is intended to support the CDC's needs through August 31, 2022. Illumina has a history of providing sequencing equipment, consumables, and services to...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $241,046.40 firm fixed-price purchase order to Illumina, Inc. to provide reagents and supplies. The award has no set-aside designation. Illumina is a manufacturer and provider of genetic sequencing instruments and analytical products. This award aligns with Illumina's past prime federal contracts to support genomic sequencing and analysis for various government agencies including the CDC,...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $22,376.85 contract is for the provision of an ISEQ 100 SYSTEM, with a completion date of March 1, 2026. This award does not have a set-aside designation. Illumina has previously received prime federal contracts from agencies such as the NIH,...
- This firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Illumina, Inc., a for-profit manufacturer of sequencing and array-based genomic analysis solutions. The $98,094.00 contract is for the provision of laboratory equipment, with no set-aside designation. Based on Illumina's past federal contract work, the equipment is likely to include Next-Generation DNA sequencing systems, reagents, and related...
- The Centers for Disease Control and Prevention (CDC) awarded a $7,303.60 firm fixed price purchase order to Illumina, Inc. to provide supplies in support of the agency's programs. The contract has a period of performance from August 14, 2023 through September 10, 2023 and will be performed in San Diego, California. As the prime contractor, Illumina will deliver supplies to the CDC's Pittsburgh location. No major subcontractors or set aside designations were identified. The funding supports the...
- This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $85,056.40 contract is for the delivery of laboratory reagents, with an ultimate completion date of July 31, 2022. The contract does not have a set-aside designation. Illumina has previously received federal prime contract and subcontract awards from agencies like the National...